Brief: Alto Neuroscience Announces Robust Replication Of EEG Biomarker
09/09/2025 12:28
Sept 9 (Reuters) - Alto Neuroscience Inc ANRO.N: ALTO NEUROSCIENCE ANNOUNCES ROBUST REPLICATION OF EEG BIOMARKER TO OBJECTIVELY IDENTIFY PATIENTS WITH COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA Source text: ID:nBwfcxtra Further company coverage: ANRO.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alto Neuroscience
See all newsBrief: Alto Neuroscience Promotes Nick Smith To President And Chief Financial Officer
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Brief: Alto Neuroscience - Proposed Resale Of Up To 6 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics
Brief: Alto Neuroscience Reports Topline Data From Phase 2 Proof-Of-Concept Study Of Alto-101 And Highlights Pipeline Advancements